Advair Pediatric Once-Daily

Completed · Phase 3 · Has a placebo group

Conditions studied: Asthma

In brief

To demonstrate if once-daily dosing of ADVAIR 100/50 once-daily has superior efficacy and comparable safety compared with FP 100mcg once-daily in pediatric subjects 4 to 11 years of age with asthma.

Key facts

Study ID

NCT00920959

Run by

GlaxoSmithKline

People needed

908

Starts

2001-11-01

Expected to finish

2004-01-01

Last updated by the study team

2016-09-15

Who can join

Age: 4 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Out-patients
• Asthma diagnosis
• Reversibility
• Short-acting beta-agonist or asthma controlled medication use

You may not qualify if…

• Life-threatening asthma
• Specified asthma medications
• Chickenpox
• Drug allergy
• Respiratory infections
• Tobacco use
• Clinical laboratory abnormalities
• Ophthalmologic conditions
• Investigation medications
• Affiliation with investigator site

Where it is running

• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — Crescent City, California, United States
• GSK Investigational Site — Dinuba, California, United States
• GSK Investigational Site — Fresno, California, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — La Jolla, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Mission Viejo, California, United States
• GSK Investigational Site — Newport Beach, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Palmdale, California, United States
• GSK Investigational Site — Panorama City, California, United States
• GSK Investigational Site — Paramount, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — Rolling Hills Estates, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Francisco, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — Sherman Oaks, California, United States
• GSK Investigational Site — Vista, California, United States
• GSK Investigational Site — Vista, California, United States
• GSK Investigational Site — Ozark, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.